Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 2
2007 1
2009 1
2010 7
2011 4
2012 7
2013 3
2014 8
2015 4
2016 6
2017 6
2018 5
2019 3
2020 4
2021 3
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Can an educational video improve the adequacy of bowel preparation for patients undergoing their first colonoscopy? Results of the EBOPS RCT.
Archer T, Corfe B, Dear K, Cole A, Foley S, Andreyev HJN, Fateen W, Baxter A, Riley S; EBOPS study group; Parra-Blanco A, Thoufeeq M. Archer T, et al. Among authors: andreyev hjn. Endosc Int Open. 2024 Mar 18;12(3):E402-E412. doi: 10.1055/a-2262-4023. eCollection 2024 Mar. Endosc Int Open. 2024. PMID: 38504742 Free PMC article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery.
Pucher PH, Coombes A, Evans O, Taylor J, Moore JL, White A, Lagergren J, Baker C, Kelly M, Gossage JA, Dunn J, Zeki S, Byrne BE, Andreyev J, Davies AR; RESTORE study group, Guy’s, St Thomas’ Oesophago-gastric research group. Pucher PH, et al. Among authors: andreyev j. Support Care Cancer. 2022 Jun;30(6):5269-5275. doi: 10.1007/s00520-022-06922-w. Epub 2022 Mar 11. Support Care Cancer. 2022. PMID: 35275293 Free PMC article.
68 results